OLR Bill Analysis

sHB 5516

AN ACT CONCERNING PRESCRIPTION DRUG ADMINISTRATION IN NURSING HOME FACILITIES.

SUMMARY:

This bill allows the medical director of a nursing home facility to establish protocols for a prescription drug formulary system. These protocols must comply with (1) American Society of Health-System Pharmacists guidelines and (2) any applicable collaborative drug therapy management agreement.

A medical director who implements such a system may make a substitution for a drug prescribed to a patient of the facility in accordance with the facility's protocols. Before making any substitution, the bill requires the medical director, or designee, to notify the prescribing physician. The bill prohibits the substitution if the prescribing physician objects or does not authorize it.

The bill specifies, notwithstanding it's provisions, that a facility must use the Department of Social Services' preferred drug lists when administering prescription drugs to Medicaid beneficiaries.

The bill applies to nursing homes, residential care homes, rest homes with nursing supervision, and chronic and convalescent nursing homes.

EFFECTIVE DATE: October 1, 2012

BACKGROUND

Collaborative Drug Therapy Management Agreements

The law permits physicians and pharmacists to enter collaborative agreements to manage the drug therapy of individual patients. These collaborative agreements must be governed by patient-specific written protocols established by the treating physician in consultation with the pharmacist. These agreements can authorize a pharmacist to implement, modify, or discontinue a drug therapy that the physician prescribes; order associated lab tests; and administer drugs (CGS 20-631).

COMMITTEE ACTION

Public Health Committee

Joint Favorable

Yea

26

Nay

0

(03/26/2012)